RAS mutations and personalized cancer care: Targeting the future

Focused insights: Data implications of ADCs in NSCLC treatment

Collaboration in chronic ITP: Improving quality of life and patient outcomes

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life

Navigating treatment choices in high-risk early-stage melanoma

Advancing the treatment of muscle-invasive bladder cancer

Supporting healing in epidermolysis bullosa: Innovations and new directions for care

Primary biliary cholangitis: Appraising the changing therapeutic landscape

Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors

Precision targeting of MET in NSCLC: A multidisciplinary approach

Vaccination strategies for pneumococcal disease: Update and perspectives on clinical need and impact

Optimizing treatment of CML in the first-line setting and beyond

Pharmacological management of agitation in Alzheimer’s dementia

Multidisciplinary insights:Navigating the challenges of systemic mastocytosis diagnosis & management

Precision targeting of MET in NSCLC: A multidisciplinary approach

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

Navigating the management of cholestatic pruritus in patients with PBC

Innovations in glaucoma care: Targeting pathophysiology to expand treatment options

Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts

Expanding HER2 horizons: Implications for NSCLC and beyond

Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease

Updates in recurrent/metastatic nasopharyngeal carcinoma: The role of immune checkpoint inhibitors

Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?

Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes

touchPANEL DISCUSSION Thyroid eye disease: An evolving continuum of care

touchFOCUS Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Thyroid eye disease: An evolving continuum of care

Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches

The path from detection to personalized long-term care for Fabry disease

Intracranial haemorrhage related to direct oral anticoagulant medications

Demystifying virology: The link between the HIV life cycle and ART

Knowledge for nurses: ADC updates in breast cancer

Early diagnosis and treatment of NMOSD: Practical insights

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

Recognizing and managing HLH in the critical care setting: Best practice for the MD team

Let’s talk about agitation in Alzheimer’s dementia: reaching a diagnosis

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

Navigating diagnosis, monitoring, and early treatment in achondroplasia: Multidisciplinary insights

Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape

Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

Harnessing the power of precision medicine for the treatment of colorectal cancer

Harnessing the power of precision medicine for the treatment of colorectal cancer

Current treatments and unmet needs in limited-stage small cell lung cancer

Multidisciplinary perspectives on management of agitation in Alzheimer’s dementia

Elevating the role of basal insulin therapy in T2D management

What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs

Expert insights in food allergy: Considerations for diagnosis & management in primary care & beyond

Diagnosing and treating patients with EoE: Tackling the difficulties

Addressing the diagnosis and management of pet allergies in primary care and beyond

The rationale for protein degradation and immunomodulation in RRMM: Latest data and clinical trials

Establishing treatment and care pathways for patients with prurigo nodularis:A patient-centric focus

Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease

Is HER2 targeting on the horizon in urothelial carcinoma?

Managing the practicalities of CAR T-cell therapies in patients with R/R MCL

New horizons in R/R follicular lymphoma: risk stratification & practicalities of CAR T-cell therapy

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy